Abstract: Clear cell carcinoma (CCC) is a low-grade malignancy that commonly arises in minor salivary glands of the oropharynx and other sites. EWSR1-ATF1 gene fusions seem to be specific for this salivary neoplasm. Testing for EWSR1-ATF1 has expanded the histologic spectrum of CCC. As one important example, many CCCs have a predominantly squamous phenotype with few clear cells, a finding that can cause confusion with squamous cell carcinoma (SqCC). P16 immunohistochemical staining to determine human papillomavirus (HPV) status has become standard practice for all oropharyngeal carcinomas showing squamous differentiation. The purpose of this study was to determine whether this practice could contribute to the difficulty in distinguishing CCC from p16-positive SqCC. The authors' surgical pathology archives were searched for cases of CCC. All cases were evaluated with p16 immunohistochemistry, high-risk HPV RNA in situ hybridization (ISH), and EWSR1 gene break-apart fluorescence ISH. Sixteen CCCs were identified. All harbored an EWSR1 rearrangement. Eleven patients were women and 5 were men. They ranged in age from 30 to 85 years (mean, 58 y). The CCCs arose in the oropharynx (tongue base or tonsil) (n = 8, 50%), oral cavity (n = 4, 25%), and nasopharynx (n = 4, 25%). Each case demonstrated clear cells, but the proportion was highly variable (10% to 90%, mean 48%), with 7 of 16 cases having <50% clear cells. Submitted diagnoses included SqCC (n = 3) and mucoepidermoid carcinoma (n = 2). Of the 3 patients diagnosed with SqCC, 1 was scheduled to undergo chemoradiation, and 1 had already completed chemoradiation. All 16 CCCs demonstrated p16 staining, with the percentage of p16-positive cells ranging from ≥ 70% (n = 2), 50% to 69% (n = 3), and 10% to 49% (n = 11). Staining was cytoplasmic and nuclear. All cases were negative for high-risk HPV by RNA ISH. CCCs regularly show squamous features, often lack prominent clear cell changes, frequently arise in the oropharynx, and invariably show p16 staining. These features may cause confusion with SqCC, particularly HPV-related oropharyngeal SqCC. P16 staining is not to be taken as unequivocal evidence of an HPV-related SqCC, even for carcinomas showing squamous differentiation and originating in the oropharynx. Failure to recognize this pitfall could result in overly aggressive treatment of a low-grade carcinoma.
C lear cell carcinoma (CCC) is a low-grade salivary gland malignancy that was initially described in 1994. 1 Although it may occur in the major salivary glands, CCC most commonly arises in the minor salivary glands at the base of tongue or palate. Until recently, CCC was regarded not as a distinct entity but rather as a diagnosis of exclusion-the default diagnosis for any clear cellpredominant salivary gland carcinoma that failed to meet criteria for some more specific tumor type such as epithelial-myoepithelial carcinoma, myoepithelial carcinoma, or mucoepidermoid carcinoma. Indecisiveness about the true nature and identity of CCC is reflected in the everevolving terminology used to properly designate it. Originally designated as "hyalinizing clear cell carcinoma," 1 it was renamed as "clear cell carcinoma, not otherwise specified" in the 2005 World Health Organization Classification of Head and Neck Tumors, 2 then as "clear cell adenocarcinoma" in the 2008 Armed Forces Institute of Pathology Fascicle of Salivary Gland Tumors," 3 and now simply as "clear cell carcinoma" in the updated 2017 World Health Organization Classification of Head and Neck Tumors. 4 The notion that CCC is nothing more than a mishmash of salivary gland tumors linked together by the presence of nondescript clear cells has been recently dismissed by Antonescu et al. 5 They found that most CCCs harbor EWSR1-ATF1 fusions not found in any other types of salivary gland tumors, supporting the verdict that CCC is a distinct tumor entity. 5 The presence of a diagnostic molecular marker for CCC has now allowed for a more complete appreciation of its full histologic spectrum that, in turn, has exposed a vulnerability in diagnosing CCC based on histology alone. For example, CCCs sometimes exhibit overt squamous differentiation, they often are not hyalinized, and they may not even be dominated by clear cells. For all of these reasons, CCCs run the risk of being misdiagnosed as high-grade squamous cell carcinomas (SqCCs), particularly when they arise from minor salivary glands of the oropharynx and other mucosal sites.
A majority of SqCCs arising in the oropharynx are now known to harbor high-risk human papillomavirus (HPV), and these HPV-related oropharyngeal SqCCs have a significantly improved survival and response to therapy compared with HPV-unrelated SqCC. 6, 7 As a result, routine HPV testing is now universally recommended for all newly diagnosed SqCCs of the oropharynx. [8] [9] [10] Although several HPV testing methods are available, p16 immunohistochemistry is now accepted as a reliable standalone test for determining the HPV status oropharyngeal SqCCs. 9, 10 For SqCCs arising within the oropharynx, p16 staining is highly sensitive and specific such that p16 staining has become the diagnostic equivalent of HPV-positive SqCC. Few if any pitfalls associated with positive p16 staining in oropharyngeal carcinomas are currently recognized. The purpose of this study was to establish the p16 status of CCCs in an effort to determine whether p16 staining would clarify or confound its distinction from SqCC, particularly for those tumors arising in the oropharynx.
MATERIALS AND METHODS

Cases
With IRB approval (0001336), cases of CCC were retrieved from the authors' surgical pathology archives including their consultation files. Basic demographic information, tumor location, and submitted diagnosis (if any) were recorded. All cases were reviewed centrally by 2 study pathologists (J.A.B., W.H.W.) to confirm the diagnosis and document the proportion of clear cells within the tumor.
Fluorescence In Situ Hybridization
Fluorescence in situ hybridization was performed on formalin-fixed paraffin-embedded (FFPE) sections using a commercially available EWSR1 dual color break-apart probe (ZTV-Z-2096-200; ZytoVision, Germany). The probe is designed to detect translocations involving the chromosomal region 22q12.2 harboring the EWSR1 gene. Before hybridization the slides were deparaffinized using a VP 2000 processor (Abbott Molecular, Des Plains, IL). The slides and the EWSR1 probe were codenatured at 80°C for 7 minutes and allowed to anneal over night at 37°C in humidified atmosphere. At the end of the incubation the slides were washed in 2× saline-sodium citrate/0.3% NP-40 for 2 minutes at 72°C and for 2 minutes at room temperature in 2× saline-sodium citrate. The slides were counterstained with DAPI and a cover slip was applied using Vectashiled mounting medium (H-1000; Vector Laboratories Inc.). A fluorescence microscope was used to evaluate the probe pattern. Cells with 2 fusion signals of 1 orange and 1 green fluorochrome were scored as normal, and considered negative for EWSR1 rearrangement. A signal pattern consisting of 1 fusion signal and 1 orange and 1 green signal, at distance from each other, indicates 1 normal 22q12.2 locus and 1 locus affected by translocation.
Immunohistochemistry P16 (clone INK4a, prediluted by manufacturer; MTM Laboratories, Heidelberg, Germany) immunohistochemical studies were performed on 5-μm-thick sections prepared from FFPE tissue using standard autostaining protocols on a Ventana Benchmark XT 
RESULTS
The results are summarized in Table 1 . Sixteen CCCs were identified including 4 routine and 12 consult cases. Each case harbored a EWSR1 gene fusion as demonstrated by fluorescence in situ hybridization (Fig. 1,  inset) . They occurred in 11 women and 5 men ranging in age from 30 to 85 years (mean, 58 y). Eight (50%) arose in the oropharynx (7 base of tongue and 1 tonsil), 4 (25%) in the oral cavity (1 retromolar trigone, 1 gingiva, 1 hard and soft palate, and 1 oral tongue), and 4 (25%) in the nasopharynx. Each case demonstrated some cells with clear cytoplasm, but the proportion was highly variable, ranging from 10% to 90% clear cells (mean, 48%) with 7 of 16 cases having <50% clear cells (Figs. 1A-C, 2A) . In 4 of 16 cases the CCC exhibited surface epithelial involvement (Fig. 1A) but squamous dysplasia/carcinoma in situ was not identified.
All 16 cases showed some immunoreactivity for p16. The extent of staining was variable, ranging from 5% to 80% of cells (mean, 30%). P16 staining was seen in ≥ 70% of cells in 2 cases, 50% to 69% of cells in 3 cases, and 10% to 49% of cells in 11 cases. In all cases, the p16 immunostaining was nuclear and cytoplasmic, with a nuclear predominance (Fig. 2B ). All cases were negative for highrisk HPV by RNA in situ hybridization (Fig. 2B, inset) .
Twelve of 16 cases were submitted with a final or preliminary diagnosis from the contributing pathologist, including SqCC (n = 3), CCC (n = 3), mucoepidermoid carcinoma (n = 2), low-grade carcinoma with clear cells cannot exclude SqCC (n = 1), salivary carcinoma not otherwise specified cannot exclude SqCC (n = 1), lowgrade adenocarcinoma not otherwise specified (n = 1), and carcinoma with clear cell features (n = 1). One of the patients originally diagnosed as SqCC was scheduled to undergo chemoradiation, and another patient diagnosed as p16-positive oropharyngeal SqCC had already completed chemoradiation but with no tumor response.
DISCUSSION
Over the past several years, an expanding list of salivary gland neoplasms has been shown to harbor characteristic gene fusions. CCC (EWSR1-ATF1), 5 mucoepidermoid carcinoma (CRTC1-MAML2 or CRTC3-MAML2), 11, 12 adenoid cystic carcinoma (MYB-NFIB or MYBL1-NFIB), 13,14 secretory carcinoma (ETV6-NTRK3), 15 and polymorphous adenocarcinoma (PRKD1-3 partnered with various genes) 16 are now known to harbor tumor-specific gene fusions. The presence of these recurring tumor-specific gene fusions has given pathologists a diagnostic benchmark for tumor classification that has, in turn, facilitated an appreciation for phenotypic divergence within salivary gland tumor types. For example, the detection of MAML2 rearrangements in Warthin-like and oncocytic neoplasms has confirmed these as phenotypic variants of mucoepidermoid carcinomas. 17, 18 Along these same lines, the discovery of tumor-specific EWSR1-ATF1 fusions in CCC has expanded the range of its histologic characteristics. It is now recognized that CCCs sometimes lack a predominance of clear cells, involve the surface epithelium, demonstrate well-developed squamous features, and even produce mucin. Not surprisingly, CCCs run the risk of being misdiagnosed as either SqCC or mucoepidermoid carcinoma when tumor classification is based on morphologic features alone. 19, 20 Indeed, in our limited series of CCCs, 7 were misdiagnosed by the submitting pathologist as either SqCC (n = 3), cannot exclude SqCC (n = 2), or mucoepidermoid carcinoma (n = 2). For infiltrative carcinomas of the head and neck that show squamous differentiation, the differential diagnosis should not invariably be restricted to SqCC, especially for those tumors that lack conventional surface dysplasia and overt keratinization, demonstrate a more uniform cell population without high-grade features, and exhibit varying degrees of cytoplasmic clearing and stromal hyalinization. Some of these may represent CCCs and require confirmative EWSR1-ATF1 testing.
The propensity of CCC to be misclassified as SqCC may be exacerbated in the oropharynx, a site where carcinomas showing squamous differentiation routinely undergo testing to determine HPV status. The confusion may also extend to the nasopharynx where 25% of our CCCs occurred and where emerging evidence suggests HPVrelated SqCC also arise and are typically treated nonsurgically. 21, 22 We found that CCC commonly demonstrates p16 positivity, even in a diffuse pattern and with a nuclear and cytoplasmic distribution-a pattern and distribution that has been tightly correlated with integrated high-risk HPV. But even though all of the CCCs demonstrated some degree of p16 staining, none were found to harbor transcriptionally active high-risk HPV. This dichotomy highlights the danger in accepting p16 staining alone as unequivocal evidence of an HPV-related carcinoma, even when dealing with oropharyngeal carcinomas showing squamous differentiation.
Although confusing CCC with HPV-related SqCC is understandable, it is a significant diagnostic error that carries serious clinical consequences. CCC is a low-grade carcinoma that is readily cured by surgical excision. HPVrelated SqCC, on the other hand, is high-grade carcinoma that is often treated by various therapeutic modalities including radiation therapy with or without chemotherapy. Two of the study patients had or were about to receive chemoradiation based on an erroneous diagnosis of SqCC, even though CCCs are not known to respond to SqCC chemotherapy protocols. The future use of HPV-specific therapies such as therapeutic vaccines only further underscores the need to clearly separate CCC from HPVSqCC for oropharyngeal carcinomas in the oropharynx showing squamous differentiation and p16 positivity. 23 Recognition of the pattern of p16 immunostaining is crucial to its interpretation as a surrogate HPV marker. According to recent College of American Pathologists guidelines, to regard an oropharyngeal carcinoma as p16 positive, ≥ 70% of cells must be positive, staining should be both nuclear and cytoplasmic, and moderate to strong in intensity. 10 For SCC not meeting these criteria, p16 should be regarded as either negative (< 50% staining), or equivocal ( > 50% but <70% staining, or > 70% but weak intensity). 10 Close attention to these criteria is useful in avoiding the pitfall of diagnosing p16-positive CCC as HPV-related SCC. While all CCCs demonstrated some p16 immunolabeling, only 2 of 16 cases were positive in ≥ 70 of cells and would have been called positive by these criteria.
In conclusion, CCCs frequently arise in the oropharynx, often show well-developed squamous features, often lack prominent clear cell features, and are invariably p16 positive. This profile may cause confusion with SCC in general, and with HPV-related oropharyngeal SCC in particular, with significant clinical consequences. As a result, p16 staining by itself should not be taken as unequivocal evidence of an HPV-related SCC, even for carcinomas showing squamous differentiation and originating in the oropharynx.
